Xiong Lishou, Wang Yilin, Gong Xiaorong, Chen Minhu
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan II Road, Guangzhou, 510080, People's Republic of China.
Department of Gastroenterology, The First People's Hospital of Foshan, Foshan, 528000, People's Republic of China.
J Health Popul Nutr. 2017 Nov 21;36(1):38. doi: 10.1186/s41043-017-0113-1.
Symptoms associated with lactose intolerance (LI) and diarrhea-predominant irritable bowel syndrome (IBS-D) are almost the same. These disease entities are difficult to differentiate clinically. In practice, differential diagnosis depends on self-reported patient milk intolerance. However, there is limited data on the prevalence of LI in China. The aim of this study was to investigate the prevalence of LI in IBS-D patients and asymptomatic healthy controls.
Lactose malabsorption (LM) was diagnosed by a lactose hydrogen breath test (HBT) and was defined by peak breath H excretion over the baseline level of ≥ 20 ppm. LI-related symptoms were monitored for 8 h following lactose administration. LI was defined in LM patients with positive symptoms during the observation time. Patients with IBS-D were additionally asked if they were intolerant to milk.
A total of 109 eligible IBS-D patients (Rome III criteria) and 50 healthy controls were enrolled in this study. Except for hydrogen non-producers, the prevalence of LM did not differ between IBS-D patients and the control group (85%, 82/96 vs 72%, 34/47; P = 0.061). There was, however, a higher LI prevalence in IBS patients than in healthy subjects (45%, 43/96 vs 17%, 8/47; P = 0.002). Sensitivity, specificity, and positive and negative predictive values of self-reported milk intolerance for detecting LI were 58, 58, 53, and 63%, respectively.
Prevalence of LI is significantly higher in IBS-D patients than in healthy subjects. Self-reported milk intolerance is a poor diagnostic predictor of LI.
乳糖不耐受(LI)和腹泻型肠易激综合征(IBS-D)相关症状几乎相同。这些疾病实体在临床上难以区分。在实际操作中,鉴别诊断依赖于患者自我报告的牛奶不耐受情况。然而,中国关于LI患病率的数据有限。本研究旨在调查IBS-D患者和无症状健康对照者中LI的患病率。
通过乳糖氢呼气试验(HBT)诊断乳糖吸收不良(LM),定义为呼气氢排泄峰值超过基线水平≥20 ppm。在给予乳糖后监测8小时与LI相关的症状。在观察期内有阳性症状的LM患者被定义为LI。IBS-D患者还被询问是否对牛奶不耐受。
本研究共纳入109例符合罗马III标准的IBS-D患者和50例健康对照者。除了不产氢者外,IBS-D患者和对照组之间LM的患病率没有差异(85%,82/96 vs 72%,34/47;P = 0.061)。然而,IBS患者中LI的患病率高于健康受试者(45%,43/96 vs 17%,8/47;P = 0.002)。自我报告的牛奶不耐受用于检测LI的敏感性、特异性、阳性预测值和阴性预测值分别为58%、58%、53%和63%。
IBS-D患者中LI的患病率显著高于健康受试者。自我报告的牛奶不耐受对LI的诊断预测价值较差。